Highlights and Quick Summary
- EPS Growth (diluted) for the quarter ending February 28, 2023 was -100.0% (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly EPS Growth (diluted) decreased by -Infinity%
- Annual EPS Growth (diluted) for 2022 was 90.0% (a 179.5% increase from previous year)
- Annual EPS Growth (diluted) for 2021 was 32.2% (a -102.98% decrease from previous year)
- Annual EPS Growth (diluted) for 2020 was -1080.0% (a 680.01% increase from previous year)
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EPS Growth (diluted) of Organigram Holdings Inc.
Most recent EPS Growth (diluted)of OGI including historical data for past 10 years.Interactive Chart of EPS Growth (diluted) of Organigram Holdings Inc.
Organigram Holdings Inc. EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -100.0% | – | – | – | – |
| 2022 | 0.0% | 71.43% | 0.0% | 95.45% | 90.0% |
| 2021 | 100.0% | 53.33% | 97.3% | -633.33% | 32.2% |
| 2020 | -1200.0% | -36.36% | -640.0% | 0.0% | -1080.0% |
| 2019 | -106.67% | -191.67% | 86.49% | 0.0% | -138.46% |
| 2018 | – | – | 1600.0% | 209.09% | 250.12% |
| 2017 | – | – | – | – | -1239.47% |
| 2016 | – | – | – | – | 108.78% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic